Absence of mutations and identification of two polymorphisms in the SSCP and sequence analysis of p21CK1 gene in malignant gliomas
- 4 July 1995
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 62 (1) , 115-117
- https://doi.org/10.1002/ijc.2910620121
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Stifled by inhibitionsNature, 1994
- Increasing complexity of the karyotype in 50 human gliomasCancer Genetics and Cytogenetics, 1994
- Evidence of allelic imbalance of chromosome 6 in human astrocytomasNeurology, 1994
- The p53 Gene and Protein in Human Brain TumorsJournal of Neuropathology and Experimental Neurology, 1994
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Wild-type p53 binds to the TATA-binding protein and represses transcription.Proceedings of the National Academy of Sciences, 1992
- Wild-type p53 is a cell cycle checkpoint determinant following irradiation.Proceedings of the National Academy of Sciences, 1992
- Clonal expansion of p53 mutant cells is associated with brain tumour progressionNature, 1992